Interview: Developments in the European cannabis market

25.06.2019

Cannabis products have become increasingly diverse in Europe and close monitoring of their potency and potential health effects is essential. These are among the conclusions of a new report published today by the EU drugs agency (EMCDDA) ahead of International day against drug abuse and illicit trafficking (26 June). The report — Developments in the European cannabis market — provides an overview of emerging and established cannabis products in Europe.

Related

Main subject
Keywords
Type
  • Creative Commons Attribution 4.0 International (CC BY 4.0)

Related assets in the Media library

Thumbnail of the webinar recording on cannabis regulation in Europe
EMCDDA Webinar: Cannabis regulation in Europe — country experiences
Screenshot from the webinar on cannabis control approaches
EMCDDA webinar: Cannabis control approaches across Europe
Infograhics shows overview of statistics of clients entering treatment for cannabis use in Europe. Most are men, in stable accomodation and self-referred. There are a range of employment statuses. Most are in stable accomodation.
Infographic: clients entering treatment for cannabis in Europe
Some key cannabis prevalance use data for young adults in Europe. Less than 20% have used cannabis in the last year. There are wide variations between countries, from 2% to over 20%. More men report using than women. Frequency of use varies widely.
Cannabis use in the last year in Europe – young adults (15-34)
Screenshot of the EMCDDA webinar on health and social responses to cannabis showing chair person Jane Mounteney and a slide presenting the European Responses Guide
EMCDDA Webinar: Health and social responses to cannabis problems in Europe — time for a paradigm shift?
Interior of medical cannabis growing facility
Interior of medical cannabis growing facility
Top